膀胱癌中的癌相关成纤维细胞:起源、生物学与治疗机会
本文综述膀胱癌(BLCA)中癌相关成纤维细胞(CAF)的起源、亚型、标志物及表型功能特征,指出单细胞RNA测序和空间转录组学可精细描绘正常膀胱与BLCA中成纤维细胞表型,批量和单细胞转录组分析揭示非肌层浸润性和肌层浸润性BLCA存在CAF含量不同的亚型,临床前研究和早期临床试验正尝试联合靶向CAF及其效应分子与免疫微环境。
要点
- CAF是膀胱癌肿瘤微环境中突出且异质的细胞群体,与肿瘤发生、进展和不良预后相关。
- 单细胞RNA测序和空间转录组学可高分辨率绘制正常膀胱与膀胱癌中成纤维细胞的表型多样性。
- 非肌层浸润性和肌层浸润性膀胱癌存在CAF含量不同的亚型,联合靶向CAF与免疫微环境是潜在治疗方向。
核心结论
- 当前对膀胱癌CAF和肿瘤微环境的认识正日益应用于改进膀胱癌治疗,但仍需更深入理解膀胱癌中CAF的生物学。
研究设计与样本
- 综述:在PubMed检索以「cancer associated fibroblast」和「bladder cancer」或「urothelial cancer」发表的手稿,审阅所有摘要并分析所有相关手稿全文,另纳入所选其他肿瘤CAF手稿。
主要发现
- CAF在膀胱癌中的研究不如其他肿瘤广泛。
- 单细胞RNA测序和空间转录组学可准确绘制并分子定义正常膀胱和膀胱癌中成纤维细胞的表型。
- 批量转录组分析揭示非肌层浸润性和肌层浸润性膀胱癌均存在亚型,这些亚型在CAF含量方面显示不同特征。
- 本文提供了这些肿瘤亚型中CAF表型多样性的更高分辨率图谱。
- 临床前研究和近期有前景的临床试验通过联合靶向CAF或其效应分子与免疫微环境来利用这些知识。
关键数值与推荐
- 非肌层浸润性和肌层浸润性膀胱癌的亚型在CAF含量方面显示不同特征。
临床怎么用
- 原文未据此给出推荐。
局限性
- CAF在膀胱癌中的研究不如其他肿瘤广泛。
- 仍需更深入理解膀胱癌中CAF的生物学。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Bladder cancer (BLCA) is a highly prevalent tumour and a health problem worldwide, especially among men. Recent work has highlighted the relevance of the tumour microenvironment (TME) in cancer biology with translational implications. Cancer-associated fibroblasts (CAFs) are a prominent, heterogeneous population of cells in the TME. CAFs have been associated with tumour development, progression, and poor prognosis in several neoplasms. However, their role in BLCA has not yet been exploited deeply. OBJECTIVE: To review the role of CAFs in BLCA biology and provide an understanding of CAF origin, subtypes, markers, and phenotypic and functional characteristics to improve patient management. EVIDENCE ACQUISITION: A PubMed search was performed to review manuscripts published using the terms "cancer associated fibroblast" and "bladder cancer" or "urothelial cancer". All abstracts were reviewed, and the full content of all relevant manuscripts was analysed. In addition, selected manuscripts on CAFs in other tumours were considered. EVIDENCE SYNTHESIS: CAFs have been studied less extensively in BLCA than in other tumours. Thanks to new techniques, such as single-cell RNA-seq and spatial transcriptomics, it is now possible to accurately map and molecularly define the phenotype of fibroblasts in normal bladder and BLCA. Bulk transcriptomic analyses have revealed the existence of subtypes among both non-muscle-invasive and muscle-invasive BLCA; these subtypes display distinct features regarding their CAF content. We provide a higher-resolution map of the phenotypic diversity of CAFs in these tumour subtypes. Preclinical studies and recent promising clinical trials leverage on this knowledge through the combined targeting of CAFs or their effectors and the immune microenvironment. CONCLUSIONS: Current knowledge of BLCA CAFs and the TME is being increasingly applied to improve BLCA therapy. There is a need to acquire a deeper understanding of CAF biology in BLCA. PATIENT SUMMARY: Tumour cells are surrounded by nontumoural cells that contribute to the determination of the behaviour of cancers. Among them are cancer-associated fibroblasts. The "neighbourhoods" established through these cellular interactions can now be studied with much greater resolution. Understanding these features of tumours will contribute to the designing of more effective therapies, especially in relationship to bladder cancer immunotherapy.
引用
- Caramelo B, Zagorac S, Corral S, et al. Cancer-associated Fibroblasts in Bladder Cancer: Origin, Biology, and Therapeutic Opportunities. Eur Urol Oncol. 2023. PMID: 36890105. doi:10.1016/j.euo.2023.02.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。